Study Suggests That Improved Treatment Options are Making a Difference for Juvenile Idiopathic Arthritis Patients
angelsalamag054 / Pixabay

Study Suggests That Improved Treatment Options are Making a Difference for Juvenile Idiopathic Arthritis Patients

According to a story from Juvenile Arthritis News, a recent study shows that a greater percentage of children with juvenile idiopathic arthritis are participating in school sports activities in the…

Continue Reading Study Suggests That Improved Treatment Options are Making a Difference for Juvenile Idiopathic Arthritis Patients

New Discovery Could Lead to New Treatments for Anemia in Juvenile Idiopathic Arthritis, Lupus, and Malaria

Juvenile idiopathic arthritis, Lupus, and Malaria are diseases which currently have limited treatment options. But a new discovery by researchers at the Benaroya Research Institute (BRI) could potentially lead to…

Continue Reading New Discovery Could Lead to New Treatments for Anemia in Juvenile Idiopathic Arthritis, Lupus, and Malaria
New Approval Gives Juvenile Idiopathic Arthritis Patients More Options
kfuhlert / Pixabay

New Approval Gives Juvenile Idiopathic Arthritis Patients More Options

On November 26, 2018, the FDA approved a new autoinjector for individuals with severe rheumatoid arthritis (RA), giant cell arteritis, and polyarticular or systemic juvenile idiopathic arthritis (aged 2 and older). It's…

Continue Reading New Approval Gives Juvenile Idiopathic Arthritis Patients More Options
Four New Drugs Accepted by the Scottish Medicines Consortium
qimono / Pixabay

Four New Drugs Accepted by the Scottish Medicines Consortium

The Scottish Medicines Consortium, a committee that advises NHS Scotland on what medicines they should provide, has accepted four new drugs for use. These are gemtuzumab ozogamicin for acute myeloid…

Continue Reading Four New Drugs Accepted by the Scottish Medicines Consortium
Drug Label Expanded in the UK for Treating Rare Inflammatory Diseases
byrev / Pixabay

Drug Label Expanded in the UK for Treating Rare Inflammatory Diseases

According to a story from Hospital Healthcare Europe, The European Medicines Agency approved Kineret last year, an anti-inflammatory drug developed by Sobi. In the UK, Kineret is an approved treatment…

Continue Reading Drug Label Expanded in the UK for Treating Rare Inflammatory Diseases
The FDA Has Approved a New Form of the Drug Actemra For Polyarticular Juvenile Idiopathic Arthritis
Source: Pixabay

The FDA Has Approved a New Form of the Drug Actemra For Polyarticular Juvenile Idiopathic Arthritis

The U.S. Food and Drug Administration (FDA) has just approved a subcutaneous version of a drug called Actemra (tocilizumab) for treating patients with active polyarticular juvenile idiopathic arthritis (PJIA) who…

Continue Reading The FDA Has Approved a New Form of the Drug Actemra For Polyarticular Juvenile Idiopathic Arthritis
Let’s Come Together for World Autoimmune Arthritis Day!
Source: Pixabay

Let’s Come Together for World Autoimmune Arthritis Day!

Sunday, May 20th is World Autoimmune Arthritis Day! The global awareness day is aimed at raising money, consciousness, and solidarity for the millions of people who suffer from one of many arthritic…

Continue Reading Let’s Come Together for World Autoimmune Arthritis Day!
A Common Virus is a Risk Factor for Seven Serious Diseases
Source: Pixabay

A Common Virus is a Risk Factor for Seven Serious Diseases

A study carried out by researchers at Cincinnati Children’s Hospital has discovered that the extremely common Epstein-Barr virus is a risk factor for seven diseases, including lupus and multiple sclerosis.…

Continue Reading A Common Virus is a Risk Factor for Seven Serious Diseases
A Drug for Still’s Disease Has Been Approved in Europe
Source: Pixabay

A Drug for Still’s Disease Has Been Approved in Europe

A drug called Kineret has been approved by the European Commission in 28 European countries for the treatment of both adult-onset and juvenile-onset Still’s disease, reports Check Orphan. Still’s disease…

Continue Reading A Drug for Still’s Disease Has Been Approved in Europe
TNF Inhibitors May Put Children at Risk For Rare Cancers, Study Says
Source: pixabay.com

TNF Inhibitors May Put Children at Risk For Rare Cancers, Study Says

According to an article from Righting Injustice, a recent study suggests that TNF inhibitors may increase the risk of rare cancers in pediatric patients. The study recommends that children that…

Continue Reading TNF Inhibitors May Put Children at Risk For Rare Cancers, Study Says
After Struggling With Juvenile Idiopathic Arthritis, An 11-Year-Old Girl Gains Access to Crucial Treatment
source: pixabay.com

After Struggling With Juvenile Idiopathic Arthritis, An 11-Year-Old Girl Gains Access to Crucial Treatment

According to a story from the Vancouver Sun, 11-year-old Jaylene Prime from British Columbia was able to obtain access to a critical treatment for her juvenile idiopathic arthritis. The drug,…

Continue Reading After Struggling With Juvenile Idiopathic Arthritis, An 11-Year-Old Girl Gains Access to Crucial Treatment
Doctors Call To Standardize Treatment in Patients With Juvenile Idiopathic Arthritis
source: pixabay.com

Doctors Call To Standardize Treatment in Patients With Juvenile Idiopathic Arthritis

According to a story from Specialty Pharmacy Times, medical professions are starting to recognize the need for a new standardized treatment plan for pediatric rheumatic diseases. Pediatric diseases are illnesses…

Continue Reading Doctors Call To Standardize Treatment in Patients With Juvenile Idiopathic Arthritis
PharmaCare in British Columbia Refuses to Cover Medication for Juvenile Idiopathic Arthritis
source: pixabay.com

PharmaCare in British Columbia Refuses to Cover Medication for Juvenile Idiopathic Arthritis

According to a story from CBC News, Jillian Lanthier's son Landen Alexa was diagnosed with a severe and rare form of juvenile idiopathic arthritis at six years old. Although he…

Continue Reading PharmaCare in British Columbia Refuses to Cover Medication for Juvenile Idiopathic Arthritis